0.0350
0.0000
(0.00%)
At close: April 11 at 2:50:48 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
44.2490
44.2490
-2,304.3400
-6,942.3330
-2,601.5610
Investing Cash Flow
-1.8150
-1.8150
--
-3.8660
-29.8780
Financing Cash Flow
--
--
--
--
13,506.8340
End Cash Position
4,954.1420
4,954.1420
4,911.7080
7,216.0480
14,162.2470
Interest Paid Supplemental Data
-0.1570
-0.1570
0.1570
--
0.0630
Capital Expenditure
-1.8150
-1.8150
--
-3.8660
-29.8780
Issuance of Capital Stock
--
--
--
--
13,506.8340
Free Cash Flow
42.4340
42.4340
-2,304.3400
-6,946.1990
-2,631.4390
6/30/2021 - 7/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
BTC.AX BTC Health Limited
0.0500
0.00%
TRP.AX Tissue Repair Ltd
0.2400
+2.13%
RNV.AX RENERVE FPO [RNV]
0.1050
-4.55%
CHM.AX Chimeric Therapeutics Limited
0.0040
-20.00%
1AI.AX Algorae Pharmaceuticals Limited
0.0050
0.00%
CMB.AX Cambium Bio Limited
0.2800
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
ATX.AX Amplia Therapeutics Limited
0.0530
+1.92%